CoChat

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia

Open access
Jiang, Xi, Hu, Chao, Ferchen, Kyle, Nie, Ji, Cui, Xiaolong, Chen, Chih-Hong, Cheng, Liting, Zuo, Zhixiang, Seibel, William, He, Chunjiang, Tang, Yixuan, Skibbe, Jennifer R., Wunderlich, Mark, Reinhold, William C., Dong, Lei, Shen, Chao, Arnovitz, Stephen, Ulrich, Bryan, Lu, Jiuwei, Weng, Hengyou, Su, Rui, Huang, Huilin, Wang, Yungui, Li, Chenying, Qin, Xi, Mulloy, James C., Zheng, Yi, Diao, Jiajie, Jin, Jie, Li, Chong, Liu, Paul P., He, Chuan, Chen, Yuan, Chen, Jianjun · 2017 · Nature Communications
Cited by 68

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Effective therapy of acute myeloid leukemia (AML) remains an unmet need. DNA methylcytosine dioxygenase Ten-eleven translocation 1 (TET1) is a critical oncoprotein in AML. Through a series of data analysis and drug screening, we identified two compounds (i.e., NSC-311068 and NSC-370284) that selectively suppress TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, and effectively inhibit cell viability in AML with high expression of TET1 (i.e., TET1-high AML), including AML carrying t(11q23)/MLL-rearrangements and t(8;21) AML. NSC-311068 and especially NSC-370284 significantly repressed TET1-high AML progression in vivo. UC-514321, a structural analog of NSC-370284, exhibited a more potent therapeutic effect and prolonged the median survival of TET1-high AML mice over three fold. NSC-370284 and UC-514321 both directly target STAT3/5, transcriptional activators of TET1, and thus repress TET1 expression. They also exhibit strong synergistic effects with standard chemotherapy. Our results highlight the therapeutic potential of targeting the STAT/TET1 axis by selective inhibitors in AML treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-02290-w

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 68

Metadata

Authors
Jiang, X., Hu, C., Ferchen, K., Nie, J., Cui, X., Chen, C.-H., Cheng, L., Zuo, Z., Seibel, W., He, C., Tang, Y., Skibbe, J. R., Wunderlich, M., Reinhold, W. C., Dong, L., Shen, C., Arnovitz, S., Ulrich, B., Lu, J., Weng, H., Su, R., Huang, H., Wang, Y., Li, C., Qin, X., Mulloy, J. C., Zheng, Y., Diao, J., Jin, J., Li, C., Liu, P. P., He, C., Chen, Y., & Chen, J.
Venue
Nature Communications
Published
2017-12-13
Volume
8
Issue
1
Pages
2099-2099
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2774982706
Cited by
68
References
9
FWCI
4.52
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia. https://app.cochat.ai/papers/10.1038/s41467-017-02290-w
The paper
Jiang, X., Hu, C., Ferchen, K., Nie, J., Cui, X., Chen, C.-H., Cheng, L., Zuo, Z., Seibel, W., He, C., Tang, Y., Skibbe, J. R., Wunderlich, M., Reinhold, W. C., Dong, L., Shen, C., Arnovitz, S., Ulrich, B., Lu, J., . . . Chen, J. (2017). Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia. Nature Communications. https://doi.org/10.1038/s41467-017-02290-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.